Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/100062

In Collections

This item can be found in the following collections:

Bauer, S.; Joensuu, H.; Casali, P.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; ... ; Demetri, G.D. (2013)

Results from a phase III trial (GRID) evaluating regorafenib in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics

Article / Letter to editor
All authors
Bauer, S.; Joensuu, H.; Casali, P.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; Gelderblom, H.; Hohenberger, P.; Leahy, M.; Mehren, M. von; Badalamenti, G.; Blackstein, M.; Cesne, A. le; Schoffski, P.; Maki, R.G.; Xu, J.; Nishida, T.; Kappeler, C.; Kuss, I.; Demetri, G.D.
Date
2013-10-31
Journal
Onkologie
Volume
36
Pages
180 - 181